2
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER_GOV
1
Study Type
Observational
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Multiple Myeloma
9
Lymphoma, Follicular
4
Recurrence
3
Lymphoma, B-Cell
3
Neoplasms, Plasma Cell
2
Burkitt Lymphoma
2
Spondylolisthesis
1
Spinal Stenosis
1
Spinal Cord Neoplasms
1
Smoldering Multiple Myeloma
1
Neoplasms
1
Neoplasm, Residual
1
Meningeal Carcinomatosis
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma
1
Lymphedema
1
Leukemia, Promyelocytic, Acute
1
Leukemia, Myeloid, Acute
1
Intervertebral Disc Displacement
1
Intervertebral Disc Degeneration
1
Hodgkin Disease
1
Failed Back Surgery Syndrome
1
Disease Progression
1
Disease
1
Breast Neoplasms
1
Bone Neoplasms
1
Interventions
Ibandronic Acid
8
Gemcitabine
8
Doxorubicin
6
Cyclophosphamide
6
Zoledronic Acid
5
Radiation
4
Nivolumab
4
Irinotecan
4
pembrolizumab
3
Vincristine
3
Temozolomide
3
Magnetic Resonance Spectroscopy
3
Ipilimumab
3
Docetaxel
3
Denosumab
3
Cisplatin
3
3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione
3
regorafenib
2
pegfilgrastim
2
Tranexamic Acid
2
Trabectedin
2
Surveys and Questionnaires
2
Sunitinib
2
Standard of Care
2
Radiotherapy, Intensity-Modulated
2
Radiotherapy
2
Radiosurgery
2
Quality of Life
2
Proton Therapy
2
Observation
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Bone Neoplasms
×
Transplantation, Autologous
×
Clear all
NCT00841152
2021-03-16
BAGvsTCP
Turku University Hospital
Completed
120 enrolled